Biochip Labs Inc.

Cleveland, OH Biochip Labs Inc.

UEI
K5TKCGKKA1T9
CAGE
8RJR8
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
10000 Cedar Ave 3 139, Cleveland, OH 44106, USA
Website
biochiplabs.com
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

About Biochip Labs Inc.

Biochip Labs Inc. is a for-profit corporate entity registered in SAM.gov since August 2020, specializing in advanced microfluidic biotechnology with a focused research portfolio on developing innovative diagnostic and drug screening technologies. The company is headquartered in Cleveland, Ohio, and concentrates on developing cutting-edge microfluidic devices and diagnostic technologies primarily targeting complex blood disorders, especially sickle cell disease. Biochip Labs Inc. provides sophisticated microfluidic biochip technologies that enable precise cellular analysis, drug screening, and diagnostic capabilities through advanced in vitro diagnostic platforms.

The company has received multiple federal grants from prominent agencies like the National Heart, Lung, and Blood Institute (NHLBI) and the National Science Foundation (NSF), focusing on developing microfluidic technologies for assessing red blood cell characteristics and creating advanced diagnostic tools. Specific grant-funded projects include developing the Microfluidic Impedance Red Cell Assay (MIRCA), which measures cellular obstruction through electrical impedance readouts, and the OcclusionChip microfluidic assay for evaluating microvascular occlusion. The grants, ranging from $256,000 to $312,371, support research into standardizing manufacturing processes, validating microfluidic devices, and creating machine learning systems for automated data analysis in drug screening applications. These projects aim to advance companion diagnostic technologies for sickle cell disease, with potential applications in personalized medicine, drug discovery, and improving treatment methodologies for complex blood disorders.

Quick answers

What is Biochip Labs Inc.'s UEI?

Biochip Labs Inc.'s Unique Entity ID (UEI) in SAM.gov is K5TKCGKKA1T9.

What is Biochip Labs Inc.'s CAGE code?

Biochip Labs Inc.'s CAGE code is 8RJR8.

Where is Biochip Labs Inc. located?

Biochip Labs Inc.'s physical address in SAM.gov is 10000 Cedar Ave 3 139, Cleveland, OH 44106, USA.

Is Biochip Labs Inc. registered in SAM.gov?

Yes. Biochip Labs Inc.'s SAM.gov registration is active through April 3, 2027.

What is Biochip Labs Inc.'s most recent federal award?

Biochip Labs Inc.'s most recent federal grant award is Manufacturing and analytical validation of the microfluidic impedance red cell assay (mirca) for commercial viability… (R42HL182546), from National Heart Lung and Blood Institute, on September 15, 2025.

On GovTribe

See Biochip Labs Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors